Inhibrx Biosciences, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ANEB
|
Anebulo Pharmaceuticals, Inc. | $1.48 | $56.28 M | -5.86 | 2 | $0 |
 CELC
|
Celcuity Inc. | $13.03 | $501.59 M | -5.14 | 55 | $0 |
 CRNX
|
Crinetics Pharmaceuticals, Inc. | $55.97 | $3.53 B | -11.86 | 290 | $4.01 M |
 DICE
|
DICE Therapeutics, Inc. | $47.55 | $2.27 B | -21.91 | 71 | $0 |
 DSGN
|
Design Therapeutics, Inc. | $5.67 | $217.51 M | -3.7 | 54 | $0 |
 ELVN
|
Enliven Therapeutics, Inc. | $24.59 | $984.95 M | -11.97 | 46 | $0 |
 ELYM
|
Eliem Therapeutics, Inc. | $5.11 | $258.33 M | -17.08 | 9 | $0 |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $8.50 | $243.38 M | -1.59 | 133 | $0 |
 HOWL
|
Werewolf Therapeutics, Inc. | $1.88 | $151.66 M | -3.17 | 45 | $19.94 M |
 IKNA
|
Ikena Oncology, Inc. | $1.71 | $84.45 M | -1.11 | 14 | $9.16 M |
 KRON
|
Kronos Bio, Inc. | $0.91 | $44.62 M | -0.37 | 58 | $6.29 M |
 LRMR
|
Larimar Therapeutics, Inc. | $6.16 | $611.84 M | -9.99 | 42 | $0 |
 LYEL
|
Lyell Immunopharma, Inc. | $0.94 | $619.50 M | -2.7 | 224 | $130,000 |
 MACK
|
Merrimack Pharmaceuticals, Inc. | $15.15 | $223.75 M | -168.11 | 0 | $0 |
 MLYS
|
Mineralys Therapeutics, Inc. | $12.50 | $652.38 M | -6.03 | 28 | $0 |
 MRUS
|
Merus N.V. | $45.72 | $3.50 B | -19.38 | 172 | $43.95 M |
 OPT
|
Opthea Limited | $3.16 | $214.34 M | -1.04 | 33 | $261,859 |
 PTGX
|
Protagonist Therapeutics, Inc. | $46.20 | $2.04 B | 13.7 | 126 | $60.00 M |
 STOK
|
Stoke Therapeutics, Inc. | $11.44 | $774.50 M | -6.14 | 110 | $8.78 M |
 VRDN
|
Viridian Therapeutics, Inc. | $20.07 | $776.72 M | -2.71 | 94 | $314,000 |